Evaluating Safety and Efficacy of Rabbit Antithymocyte Globulin Induction in Elderly Kidney Transplant Recipients

Safety And Efficacy ◽

Low dose rabbit antithymocyte globulin is non-inferior to higher dose in low-risk pediatric kidney transplant recipients

Pediatric Nephrology ◽

10.1007/s00467-021-05407-y ◽

2022 ◽

Author(s):

Vaka K. Sigurjonsdottir ◽

Lynn Maestretti ◽

Anne McGrath ◽

Waldo Concepcion ◽

Amy Gallo ◽

...

Keyword(s):

Kidney Transplant ◽

Antithymocyte Globulin ◽

Low Dose ◽

Low Risk ◽

Transplant Recipients ◽

Efficacy and Safety of Extended-Duration Inpatient-to-Outpatient Rabbit Antithymocyte Globulin Induction in De Novo Kidney Transplant Recipients

10.1097/tp.0b013e31825c58c0 ◽

2012 ◽

Vol 94 (5) ◽

pp. 506-512 ◽

Cited By ~ 4

Author(s):

Jennifer Trofe-Clark ◽

Peter P. Reese ◽

Hina J. Patel ◽

Diane Jakobowski ◽

Simin Goral ◽

...

Keyword(s):

Kidney Transplant ◽

Antithymocyte Globulin ◽

De Novo ◽

Efficacy And Safety ◽

Transplant Recipients ◽

Rabbit Antithymocyte Globulin ◽

Extended Duration

COMPARISON OF BASILIXIMAB TO RABBIT ANTITHYMOCYTE GLOBULIN INDUCTION IN KIDNEY TRANSPLANT RECIPIENTS.

10.1097/00007890-200004271-00179 ◽

2000 ◽

Vol 69 (Supplement) ◽

pp. S159 ◽

Cited By ~ 1

Author(s):

Ibrahim Ahmad ◽

Beverley Ketel ◽

Gary Barone ◽

Yousri Barri ◽

Kristie Reed ◽

...

Keyword(s):

Kidney Transplant ◽

Antithymocyte Globulin ◽

Transplant Recipients ◽

5 YEAR OUTCOMES IN A RANDOMIZED TRIAL COMPARING RABBIT ANTITHYMOCYTE GLOBULIN AND BASILIXIMAB IN KIDNEY TRANSPLANT RECIPIENTS: LINKING CLINICAL TRIAL DATA WITH REGISTRY DATA

10.1097/01.tp.0000332024.00282.60 ◽

2008 ◽

Vol 86 (Supplement) ◽

pp. 278-279

Author(s):

D C. Brennan ◽

M Schnitzler

Keyword(s):

Clinical Trial ◽

Randomized Trial ◽

Kidney Transplant ◽

Antithymocyte Globulin ◽

Clinical Trial Data ◽

Trial Data ◽

Registry Data ◽

Transplant Recipients ◽

Serum Sickness After Treatment With Rabbit Antithymocyte Globulin in Kidney Transplant Recipients With Previous Rabbit Exposure

American Journal of Kidney Diseases ◽

10.1053/j.ajkd.2009.06.017 ◽

2010 ◽

Vol 55 (1) ◽

pp. 141-143 ◽

Cited By ~ 27

Author(s):

Raghavender Boothpur ◽

Karen L. Hardinger ◽

Rebecca M. Skelton ◽

Brunilda Lluka ◽

Matthew J. Koch ◽

...

Keyword(s):

Kidney Transplant ◽

Antithymocyte Globulin ◽

Serum Sickness ◽

Transplant Recipients ◽

Safety and Feasibility of Outpatient Rabbit Antithymocyte Globulin Induction Therapy Administration in Kidney Transplant Recipients

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1002/phar.2116 ◽

2018 ◽

Vol 38 (6) ◽

pp. 620-627 ◽

Cited By ~ 1

Author(s):

Alexandra N. Varga ◽

David Johnson ◽

Deirdre L. Sawinski ◽

Mary Ann Lim ◽

Roy D. Bloom ◽

...

Keyword(s):

Kidney Transplant ◽

Induction Therapy ◽

Antithymocyte Globulin ◽

Transplant Recipients ◽

SAFETY AND EFFICACY OF REDUCED OR FULL DOSE OF CYCLOSPORINE (NEORAL®) IN COMBINATION WITH MYCOPHENOLATESODIUM (MYFORTIC®), BASILIXIMAB (SIMULECT®), AND STEROIDS IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS

10.1097/00007890-200407271-00225 ◽

2004 ◽

Vol 78 ◽

pp. 83 ◽

Cited By ~ 3

Author(s):

K Budde ◽

J-L Bosmans ◽

M Zeier ◽

J Sennesael ◽

U Hopt ◽

...

Keyword(s):

Kidney Transplant ◽

De Novo ◽

Transplant Recipients ◽

Safety And Efficacy ◽

Full Dose

Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft

Nephrology Dialysis Transplantation ◽

10.1093/ndt/13.10.2601 ◽

1998 ◽

Vol 13 (10) ◽

pp. 2601-2604 ◽

Cited By ~ 32

Author(s):

J Grinyo

Keyword(s):

Mycophenolate Mofetil ◽

Kidney Transplant ◽

Antithymocyte Globulin ◽

Transplant Recipients ◽

Kidney Transplant Recipients

Safety and Efficacy of Treatment of Hepatitis C in Kidney Transplant Recipients With Directly Acting Antiviral Agents

10.1097/tp.0000000000001618 ◽

2017 ◽

Vol 101 (7) ◽

pp. 1704-1710 ◽

Cited By ~ 54

Author(s):

Michelle Lubetzky ◽

Soohwan Chun ◽

Andrew Joelson ◽

Maria Coco ◽

Layla Kamal ◽

...

Keyword(s):

Hepatitis C ◽

Kidney Transplant ◽

Antiviral Agents ◽

Transplant Recipients ◽

Safety And Efficacy ◽

Efficacy Of Treatment

The Influence of Antithymocyte Globulin Dose on the Incidence of CMV Infection in High-risk Kidney Transplant Recipients Without Pharmacological Prophylaxis

10.1097/tp.0000000000003124 ◽

2020 ◽

Vol 104 (10) ◽

pp. 2139-2147 ◽

Cited By ~ 2

Author(s):

Mayara I. de Paula ◽

Sunjae Bae ◽

Ashton A. Shaffer ◽

Jacqueline Garonzik-Wang ◽

Claudia R. Felipe ◽

...

Keyword(s):

High Risk ◽

Kidney Transplant ◽

Antithymocyte Globulin ◽

Transplant Recipients ◽

Cmv Infection ◽

Pharmacological Prophylaxis